A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT02181517 · COMPLETED
Trial details
- NCT number
- NCT02181517
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.